The Chinese innovative drug market was valued at CNY709.7bn ($97.7bn) in 2023 and is expected to hit CNY753.4bn in 2024 due to the influence of medical insurance adjustments and increased R&D expenditures of pharmaceutical companies.
Innovative Drugs: China Gains Deals, But Financing Amounts Drop
China has seen a “milestone year for the overseas launch of domestically produced innovative drugs.”
More from Innovation
More from In Vivo
• By
Top 30 leaders: see the list of industry influencers highlighted in the sixth edition of In Vivo's Rising Leaders series.
• By
AI-related deal activitiy in the first quarter of 2025 was punctuated by a last-minute $600m raise for Isomorphic Labs.
• By
The process of manufacturing medicines can often be complex, expensive and harmful to the environment. Initiatives like RESILIENCE UK are seeking to simplify this process, utilizing VR technology to create a more sustainable learning environment for both students and companies.